Open the map

Thermo Fisher ScientificTMO

Life science tools · NYSE · USA

$651.98
Down 1.5% todayClose

Up 14.3% this year and +27.1% since June 26, ahead of the life science sector at +10.7%. Thermo Fisher Scientific supplies 6 mapped companies.

Market cap
$237B
This year
+14.3%
1 year
+22.8%
P/E
34.0
P/S
5.1
P/B
4.5

Price vs the life science sector

since Jun 26TMOLife science sector, equal weight
Thermo Fisher Scientific (TMO) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. TMO: +27.1% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%+30%Jun 26AugSepOct 8TMO +27.1%Sector +10.7% Thermo Fisher Scientific (TMO) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. TMO: +27.1% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%+30%Jun 26AugSepOct 8TMO+27.1%Sector+10.7%

Supply chain

6 customers
SUPPLIERS →→ CUSTOMERSNone mappedEli Lilly (LLY)LLYEli Lilly−1.6%Pfizer (PFE)PFEPfizer−0.6%Moderna (MRNA)MRNAModerna+0.3%Johnson & Johnson (JNJ)JNJJohnson & Johnson−0.8%IDEXX Laboratories (IDXX)IDXXIDEXX Laboratories+1.3%Amgen (AMGN)AMGNAmgen−1.4%TMOThermo Fisher S…

Customers 6

Open the full chain →

About Thermo Fisher Scientific

Analytical instruments on one side, the reagents and consumables that feed them on the other, sold to research laboratories and pharmaceutical companies. Patheon, its contract manufacturing arm, makes drugs for customers outright.

Theme exposure

Life science toolsCDMO exposureDiagnostics exposureBioproductionDiagnostics

Products

  • Analytical instruments
  • Reagents & consumables
  • Contract manufacturing (Patheon)

Competitors

Risks

  • Cyclical research demand
  • Acquisition integration

Same segment: Life science tools

Instruments, reagents and equipment for research, development and production. Segment 5 of 8 in the Medicine, pharma & life science value chain.

DanaherDHR−0.5%Agilent TechnologiesA−0.5%Waters CorporationWAT−1.6%IlluminaILMN−1.2%RevvityRVTY−0.9%

Compare TMO

Side by side with the largest companies in the same segment.

TMO vs DHRTMO vs ATMO vs WATTMO vs ILMNTMO vs RVTY

See where Thermo Fisher Scientific sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →